United States · Bill · S
S. 1069 (115th)
Medical Device Safety Monitoring Act
Original
Introduced
8 May 2017
Last action
8 May 2017 · Introduced
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
Sen. Casey, Robert P., Jr. [D-PA], Sen. Warren, Elizabeth [D-MA], Sen. Franken, Al [D-MN]
Subjects
Healthcare
Source updated
11 August 2025
Summary
Medical Device Safety Monitoring Act This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to support pilot projects in order to provide timely and reliable information on the safety and effectiveness of marketed medical devices. The projects must: (1) be designed to generate safety and active surveillance data, (2) inform support for safety and active surveillance activities, (3) be coordinated with a system for evaluating medical device technology that operates under a board with representation from consumer groups and device manufacturers, and (4) use electronic health data. The FDA may determine that a manufacturer's participation in a pilot project satisfies requirements regarding reporting or postmarket surveillance if the project captures adverse event information and the FDA has established procedures to publish safety information from the project. Not later than January 31, 2021, the FDA must evaluate real world evidence pilot projects, such as the ones supported by this bill, for their ability to inform decision-making and efficiently generate evidence about the safety or effectiveness of medical devices.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 May 2017
Introduced
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Source: IntroReferral
8 May 2017
Introduced
Introduced in Senate
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in Senate · 8 May 2017 · Official file
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 8 May 2017
Introduced in Senate (PDF)
Introduced in Senate · EN · 8 May 2017
Introduced in Senate
summary · EN · 8 May 2017
Sponsors
- Sen. Casey, Robert P., Jr. [D-PA] · D · Sponsor
- Sen. Warren, Elizabeth [D-MA] · D · Sponsor
- Sen. Franken, Al [D-MN] · D · Sponsor
- · sshr00 · Standing
Related records
- related to → FDA Reauthorization Act of 2017
- related to ← FDA Reauthorization Act of 2017
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/1069
- Open data entity: https://api.congress.gov/v3/bill/115/s/1069
- us · 115-s-1069 · source updated 11 August 2025